These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26270811)

  • 1. Immune-mediated and lipid-mediated platelet function in atherosclerosis.
    Ahmadsei M; Lievens D; Weber C; von Hundelshausen P; Gerdes N
    Curr Opin Lipidol; 2015 Oct; 26(5):438-48. PubMed ID: 26270811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet CD40L Modulates Thrombus Growth Via Phosphatidylinositol 3-Kinase β, and Not Via CD40 and IκB Kinase α.
    Kuijpers MJ; Mattheij NJ; Cipolla L; van Geffen JP; Lawrence T; Donners MM; Boon L; Lievens D; Torti M; Noels H; Gerdes N; Cosemans JM; Lutgens E; Heemskerk JW
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1374-81. PubMed ID: 25908768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet activation in atherogenesis associated with low-grade inflammation.
    Antoniades C; Bakogiannis C; Tousoulis D; Demosthenous M; Marinou K; Stefanadis C
    Inflamm Allergy Drug Targets; 2010 Dec; 9(5):334-45. PubMed ID: 20632958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated platelets and atherosclerosis.
    Aukrust P; Halvorsen B; Ueland T; Michelsen AE; Skjelland M; Gullestad L; Yndestad A; Otterdal K
    Expert Rev Cardiovasc Ther; 2010 Sep; 8(9):1297-307. PubMed ID: 20828352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelets: pleiotropic roles in atherogenesis and atherothrombosis.
    Linden MD; Jackson DE
    Int J Biochem Cell Biol; 2010 Nov; 42(11):1762-6. PubMed ID: 20673808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-lymphocyte cross-talk.
    Li N
    J Leukoc Biol; 2008 May; 83(5):1069-78. PubMed ID: 18198208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CD40/CD40L system: a new therapeutic target for disease.
    Zhang B; Wu T; Chen M; Zhou Y; Yi D; Guo R
    Immunol Lett; 2013 Jun; 153(1-2):58-61. PubMed ID: 23892087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelets in atherosclerosis.
    Lievens D; von Hundelshausen P
    Thromb Haemost; 2011 Nov; 106(5):827-38. PubMed ID: 22012554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential therapeutic targeting of platelet-mediated cellular interactions in atherosclerosis and inflammation.
    Nagy B; Miszti-Blasius K; Kerenyi A; Clemetson KJ; Kappelmayer J
    Curr Med Chem; 2012; 19(4):518-31. PubMed ID: 22204330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multi-functionality of CD40L and its receptor CD40 in atherosclerosis.
    Lievens D; Eijgelaar WJ; Biessen EA; Daemen MJ; Lutgens E
    Thromb Haemost; 2009 Aug; 102(2):206-14. PubMed ID: 19652870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet Function in Cardiovascular Disease: Activation of Molecules and Activation by Molecules.
    Khodadi E
    Cardiovasc Toxicol; 2020 Feb; 20(1):1-10. PubMed ID: 31784932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation.
    Inwald DP; McDowall A; Peters MJ; Callard RE; Klein NJ
    Circ Res; 2003 May; 92(9):1041-8. PubMed ID: 12676820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelets as therapeutic targets to prevent atherosclerosis.
    Nording H; Baron L; Langer HF
    Atherosclerosis; 2020 Aug; 307():97-108. PubMed ID: 32653088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The platelet as a therapeutic target for treating vascular diseases and the role of eicosanoid and synthetic PPARgamma ligands.
    O'Brien JJ; Ray DM; Spinelli SL; Blumberg N; Taubman MB; Francis CW; Wittlin SD; Phipps RP
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):68-76. PubMed ID: 17164134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of serotonin in haemostasis].
    Duerschmied D; Bode C
    Hamostaseologie; 2009 Nov; 29(4):356-9. PubMed ID: 19882076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelets: physiology and biochemistry.
    Jurk K; Kehrel BE
    Semin Thromb Hemost; 2005; 31(4):381-92. PubMed ID: 16149014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of platelet and monocyte function by the chemokine fractalkine (CX3 CL1) in cardiovascular disease.
    Flierl U; Bauersachs J; Schäfer A
    Eur J Clin Invest; 2015 Jun; 45(6):624-33. PubMed ID: 25832902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of platelet activation-inhibitory drugs.
    Rao GH; Rao AT
    Indian J Physiol Pharmacol; 1994 Apr; 38(2):69-84. PubMed ID: 8063366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD40 ligand is selectively expressed on CD4+ T cells and platelets: implications for CD40-CD40L signalling in atherosclerosis.
    Büchner K; Henn V; Gräfe M; de Boer OJ; Becker AE; Kroczek RA
    J Pathol; 2003 Oct; 201(2):288-95. PubMed ID: 14517846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
    Jennings LK
    Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.